News and Issues 1 min read The Controversy Behind Anti-Amyloid Drugs: Are We Truly Addressing Alzheimer’s? vero January 25, 2025
News and Issues 1 min read FDA Halts Use of Red 3 Dye: Understanding the Health Concerns and Legacy vero January 25, 2025
News and Issues 1 min read FDA Prohibits Red 3 Dye: Unveiling the Health Risks and Longstanding History vero January 25, 2025
News and Issues 1 min read FDA Bans Controversial Food Dye: What It Means for Your Kid’s Breakfast vero January 24, 2025
News and Issues 1 min read FDA Alerts Public on Potential Anaphylaxis Risk of MS Drug vero January 24, 2025
News and Issues 1 min read FDA Issues Critical Alert on Anaphylaxis Risk Associated with MS Drug Glatiramer Acetate vero January 24, 2025
News and Issues 1 min read Urgent FDA Alert: Life-Threatening Reactions Linked to MS Medication vero January 24, 2025
News and Issues 1 min read FDA Grants Standalone Approval for J&J’s Ketamine-Based Nasal Spray for Severe Depression vero January 23, 2025
News and Issues 1 min read BREAKTHROUGH! SPRAVATO® Approved as First Solo Medication for Treatment-Resistant Depression vero January 23, 2025